BR112012007179B8 - composto inibidor da di-hidro-orotato desidrogenase, e, formulação farmacêutica - Google Patents

composto inibidor da di-hidro-orotato desidrogenase, e, formulação farmacêutica

Info

Publication number
BR112012007179B8
BR112012007179B8 BR112012007179A BR112012007179A BR112012007179B8 BR 112012007179 B8 BR112012007179 B8 BR 112012007179B8 BR 112012007179 A BR112012007179 A BR 112012007179A BR 112012007179 A BR112012007179 A BR 112012007179A BR 112012007179 B8 BR112012007179 B8 BR 112012007179B8
Authority
BR
Brazil
Prior art keywords
dihydro
pharmaceutical formulation
compound
inhibitor compound
dehydrogenase inhibitor
Prior art date
Application number
BR112012007179A
Other languages
English (en)
Portuguese (pt)
Other versions
BR112012007179A2 (pt
BR112012007179A8 (pt
BR112012007179B1 (pt
Inventor
Marwaha Alka
Floyd David
Matthews David
Burrows Jeremy
Coteron-Lopez Jose
Phillips Margaret
K Rathod Pradipsinh
Gujjar Ramesh
A Charman Susan
Original Assignee
Univ Texas
Glaxosmithkline Investig Y Desarrolo S L
Medicines Malaria Venture Mmv
Univ Monash
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas, Glaxosmithkline Investig Y Desarrolo S L, Medicines Malaria Venture Mmv, Univ Monash, Univ Washington filed Critical Univ Texas
Publication of BR112012007179A2 publication Critical patent/BR112012007179A2/pt
Publication of BR112012007179A8 publication Critical patent/BR112012007179A8/pt
Publication of BR112012007179B1 publication Critical patent/BR112012007179B1/pt
Publication of BR112012007179B8 publication Critical patent/BR112012007179B8/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR112012007179A 2009-09-29 2010-09-28 composto inibidor da di-hidro-orotato desidrogenase, e, formulação farmacêutica BR112012007179B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24686309P 2009-09-29 2009-09-29
US61/246863 2009-09-29
PCT/US2010/050532 WO2011041304A2 (en) 2009-09-29 2010-09-28 Antimalarial agents that are inhibitors of dihydroorotate dehydrogenase

Publications (4)

Publication Number Publication Date
BR112012007179A2 BR112012007179A2 (pt) 2017-07-25
BR112012007179A8 BR112012007179A8 (pt) 2018-01-23
BR112012007179B1 BR112012007179B1 (pt) 2020-12-01
BR112012007179B8 true BR112012007179B8 (pt) 2021-05-25

Family

ID=43826848

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012007179A BR112012007179B8 (pt) 2009-09-29 2010-09-28 composto inibidor da di-hidro-orotato desidrogenase, e, formulação farmacêutica

Country Status (15)

Country Link
US (1) US9238653B2 (enrdf_load_stackoverflow)
EP (1) EP2483274B1 (enrdf_load_stackoverflow)
JP (1) JP5818266B2 (enrdf_load_stackoverflow)
CN (1) CN102741255B (enrdf_load_stackoverflow)
BR (1) BR112012007179B8 (enrdf_load_stackoverflow)
CA (1) CA2775354C (enrdf_load_stackoverflow)
DK (1) DK2483274T3 (enrdf_load_stackoverflow)
ES (1) ES2527835T3 (enrdf_load_stackoverflow)
HR (1) HRP20150066T1 (enrdf_load_stackoverflow)
ME (1) ME02020B (enrdf_load_stackoverflow)
PL (1) PL2483274T3 (enrdf_load_stackoverflow)
PT (1) PT2483274E (enrdf_load_stackoverflow)
SI (1) SI2483274T1 (enrdf_load_stackoverflow)
SM (1) SMT201500071B (enrdf_load_stackoverflow)
WO (1) WO2011041304A2 (enrdf_load_stackoverflow)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015095477A1 (en) * 2013-12-19 2015-06-25 Irm Llc [1,2,4]triazolo[1,5-a]pyrimidine derivatives as protozoan proteasome inhibitors for the treatment of parasitic diseases such as leishmaniasis
EP3072894A1 (en) * 2015-03-26 2016-09-28 Board Of Regents Of the University Of Texas System New substituted triazolopyrimidines as anti-malarial agents
EP3254679A1 (de) 2016-06-09 2017-12-13 Christian-Albrechts-Universität zu Kiel Wirkstoffe gegen protozoen und bakterien
EP3525786A4 (en) * 2016-10-12 2020-03-18 Merck Sharp & Dohme Corp. KDM5 INHIBITORS
US11690847B2 (en) 2016-11-30 2023-07-04 Case Western Reserve University Combinations of 15-PGDH inhibitors with corticosteroids and/or TNF inhibitors and uses thereof
JP2020514323A (ja) * 2017-02-06 2020-05-21 ケース ウエスタン リザーブ ユニバーシティ 短鎖デヒドロゲナーゼ活性を調節する組成物と方法
US11426420B2 (en) 2017-04-07 2022-08-30 Case Western Reserve University Inhibitors of short-chain dehydrogenase activity for treating coronary disorders
CR20250174A (es) 2018-11-21 2025-06-10 Rodeo Therapeutics Corp COMPOSICIONES Y MÉTODOS PARA MODULAR LA ACTIVIDAD DE DESHIDROGENASAS DE CADENA CORTA (Divisional 2021-0328)
EP3842100A1 (en) * 2019-12-24 2021-06-30 The Board Of Regents Of The University Of Texas System Anti-malarial agents

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5478825A (en) 1991-02-22 1995-12-26 Egis Gyogyszergyar 5-(substituted amino)-1,2,4-triazolo (1,5-A) pyrimidine derivatives
HU208693B (en) * 1991-02-22 1993-12-28 Egyt Gyogyszervegyeszeti Gyar Process for producing 1,2,4-triazolo (1,5-a) pyrimidinis derivatives and their carbicycli-tetrahydro-thiofurane-tetrahydrothiopyrane-, or tetrahydropyridine- condensated derivatives or medical preparatives containing them
US8490825B2 (en) 1999-12-08 2013-07-23 Metal Container Corporation Can lid closure and method of joining a can lid closure to a can body
CZ294535B6 (cs) * 2001-08-02 2005-01-12 Ústav Experimentální Botaniky Avčr Heterocyklické sloučeniny na bázi N6-substituovaného adeninu, způsoby jejich přípravy, jejich použití pro přípravu léčiv, kosmetických přípravků a růstových regulátorů, farmaceutické přípravky, kosmetické přípravky a růstové regulátory tyto sloučeniny obsahující
US20080027079A1 (en) * 2006-06-22 2008-01-31 Board Of Regents, University Of Texas System Dihydroorotate dehydrogenase inhibitors with selective anti-malarial activity
CN101622001A (zh) * 2007-01-26 2010-01-06 Irm责任有限公司 作为激酶抑制剂用于治疗疟原虫相关疾病的嘌呤化合物和组合物
WO2009082691A1 (en) 2007-12-21 2009-07-02 Board Of Regents, University Of Texas System Dihydroorotate dehydrogenase inhibitors with selective anti-malarial activity

Also Published As

Publication number Publication date
WO2011041304A3 (en) 2011-08-04
HRP20150066T1 (hr) 2015-02-27
EP2483274A2 (en) 2012-08-08
ES2527835T3 (es) 2015-01-30
CA2775354A1 (en) 2011-04-07
BR112012007179A2 (pt) 2017-07-25
HK1174639A1 (en) 2013-06-14
CA2775354C (en) 2019-01-15
CN102741255A (zh) 2012-10-17
US9238653B2 (en) 2016-01-19
JP5818266B2 (ja) 2015-11-18
JP2013506004A (ja) 2013-02-21
SI2483274T1 (sl) 2015-02-27
PT2483274E (pt) 2015-02-04
SMT201500071B (it) 2015-05-05
ME02020B (me) 2015-05-20
PL2483274T3 (pl) 2015-04-30
EP2483274B1 (en) 2014-10-29
EP2483274A4 (en) 2013-03-06
BR112012007179A8 (pt) 2018-01-23
CN102741255B (zh) 2015-10-07
US20120302586A1 (en) 2012-11-29
DK2483274T3 (en) 2015-01-19
WO2011041304A2 (en) 2011-04-07
BR112012007179B1 (pt) 2020-12-01

Similar Documents

Publication Publication Date Title
BR112012007179B8 (pt) composto inibidor da di-hidro-orotato desidrogenase, e, formulação farmacêutica
ECSP20027480A (es) Indolil alquil amino derivados sustituidos como nuevos inhibidores de la histona desacetilasa
BR112012023382A2 (pt) compostos, composições e métodos de uso de imidazopiridina.
ECSP067076A (es) Derivados de pirimidina urea como inhibidores de la quinasa
BR112014010407A2 (pt) compostos de azetidina, composições e seu uso como inibidores de hidrolase de epóxido solúvel
EA201200049A1 (ru) 1,3-дизамещенные производные имидазолидин-2-она в качестве ингибиторов cyp 17
CL2009000316A1 (es) Compuestos derivados de urea de benzomorfanos y sus sales, inhibidores de la enzima 11-beta-hidroxiesteroide deshidrogenasa; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento o prevencion de trastornos metabolicos.
SV2011004061A (es) Aril-piridinas como inhibidores de sintasa de aldosterona
ECSP10010419A (es) Derivados heterocíclicos de urea y métodos de uso de los mismos-211
BRPI1011657A2 (pt) derivados aminopropiônicos substituídos como inibidores de neprilisina
SV2011004077A (es) Derivados aminobutiricos sustituidos como inhibidores de neprilisina
UY33075A (es) Derivados de ciclohexano y usos de los mismos
SMT201300109B (it) Imidazopiridazincarbonitrili utili come inibitori di chinasi
UY32158A (es) Derivados heterociclicos y metodos de uso de los mismos
NO20090628L (no) Pyridizinon derivativater
BR112013011580A2 (pt) derivados de ácido bisfenil pentanoico substituído por amino como inibidores de nep
CL2013000351A1 (es) Compuestos derivados de 2-(arilamino)-3h-imidazo[4,5-b]piridina-6-carboxamida; inhibidores de la prostaglandina e2 sintasa-1 microsomal (mpges-1) composicion farmaceutica que comprende a uno de los compuestos; y uso de los compuestos en la preparacion de medicamentos para el tratamiento de enfermedades inflamatorias.
UY32203A (es) Amino pirimidinas y su uso en terapia
EA201001013A1 (ru) Бис(сульфониламино)производные для применения в терапии
CR11857A (es) Compuestos pirazolicos 436
PA8658301A1 (es) Derivados fusionados de pirazol y metodos de tratamiento de trastornos metabolicos con estos
GEP20156242B (en) 2-arylimidazole derivatives as pde10a enzyme inhibitors
EA201170680A1 (ru) Ингибиторы акт и p70 s6-киназы
UY30298A1 (es) Inhibidores de la quinasa c-fms ii
EA201270590A1 (ru) Ингибиторы акт

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 01/12/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 28/09/2010 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 11A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2640 DE 10-08-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.